Skip to main content
MCUJF
OTC Life Sciences

MEDICURE Reports Q1 Revenue Growth, But Significant Cash Burn Raises Liquidity Concerns

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.804
Mkt Cap
$8.39M
52W Low
$0.436
52W High
$1.26
52W Position info
84% above low
Off High info
36% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

MCUJF sits 84% above its 52-week low of $0.436.

Summary

Medicure Inc. reported increased Q1 2026 revenue and a narrower net loss, but a substantial cash burn from operations led to a significant drop in its cash balance, highlighting liquidity challenges.


Key Events · Earnings and Guidance · MCUJF

  • Revenue Growth

    Net revenue increased by 45% to $7.9 million in Q1 2026 from $5.4 million in Q1 2025.

  • Reduced Net Loss

    Net loss decreased to $0.4 million in Q1 2026 from $0.7 million in Q1 2025.

  • Significant Cash Burn

    Cash and cash equivalents declined from $3.8 million at December 31, 2025, to $1.5 million at March 31, 2026.

  • Negative Operating Cash Flow

    Cash flow from operating activities was negative $1.8 million in Q1 2026, compared to positive $0.7 million in Q1 2025.


Analysis · MCUJF · Life Sciences

While Medicure Inc. reported strong revenue growth and a reduced net loss for Q1 2026, the company experienced a substantial negative cash flow from operations and a significant decline in its cash reserves. This rapid cash depletion, leaving only $1.5 million in cash, raises immediate liquidity concerns for the micro-cap company, despite improved top-line performance.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MCUJF was trading at $0.80 on OTC in the Life Sciences sector, with a market capitalization of approximately $8.4M. The 52-week trading range was $0.44 to $1.26. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MCUJF - Latest Insights

MCUJF
Sep 28, 2026, 6:00 PM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $2.78 info
Change: +$0.7765 (+39%) info
Market Cap: $28.976M info
MCUJF
Aug 19, 2026, 4:35 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.915
Real-time Price: $2.78 info
Change: +$1.86 (+203%) info
Market Cap: $28.976M info
MCUJF
May 21, 2026, 5:18 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.8039
Real-time Price: $2.78 info
Change: +$1.97 (+245%) info
Market Cap: $28.976M info
MCUJF
May 21, 2026, 5:00 PM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $0.8039
Real-time Price: $2.78 info
Change: +$1.97 (+245%) info
Market Cap: $28.976M info
MCUJF
Apr 23, 2026, 6:26 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.9633
Real-time Price: $2.78 info
Change: +$1.81 (+188%) info
Market Cap: $28.976M info